...
首页> 外文期刊>Gerontology: International Journal of Experimental and Clinical Gerontology >On how insulin may influence ageing and become atherogenic throughout the insulin-like growth factor-1 receptor pathway: in vitro studies with human vascular smooth muscle cells.
【24h】

On how insulin may influence ageing and become atherogenic throughout the insulin-like growth factor-1 receptor pathway: in vitro studies with human vascular smooth muscle cells.

机译:关于胰岛素如何影响衰老并在整个胰岛素样生长因子1受体途径中致动脉粥样硬化:人体血管平滑肌细胞的体外研究。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: It is known that growth factors play a role in ageing and atherogenesis, and insulin develops mitogenic activity in vitro. OBJECTIVES: This study focuses on the pathway by which insulin induces proliferation and mobility in vascular smooth muscle cells (SMCs) compared with that of insulin-like growth factor-1 (IGF-1), because they are two basic phenomena for atherogenesis that could also help to understand the role of insulin in the ageing process. METHODS: Bromodeoxyuridine DNA incorporation, chemotaxis and the appearance of membrane ruffles were measured in cultured SMCs after incubation with insulin or IGF-1 in the presence of insulin or IGF-1 receptor-blocking antibodies. RESULTS: Insulin-induced SMC proliferation through the IGF-1 receptors; indeed, the blockade of insulin receptors does not inhibit the mitogenic influence of insulin. On the contrary, insulin-induced cell migration was inhibited by blocking the insulin receptor but not the IGF-1 receptor. Nevertheless, in less differentiated SMCs from non-confluent cultures, the migratory response was significantly higher and insulin lost its receptor specificity. It was stimulated through receptors both for insulin and IGF-1. In these cases the IGF-1 action was similar. Insulin-induced F-actin rearrangements took place through both types of receptors, but IGF-1 was a little more specific through its own receptors. CONCLUSION: The pathway activated by insulin to induce SMC proliferation is not different from that of IGF-1, whereas the unspecific mechanism inducing mobility in growing cells seems to be related to a higher sensitivity response. Cells with the highest mitotic activity have the highest mobility in which stimulation of receptor specificity is lost for either insulin or IGF-1. Extrapolating these results to in vivo, insulin could become relevant for inducing stabilization and also side effects in ageing.
机译:背景:已知生长因子在衰老和动脉粥样硬化中起作用,并且胰岛素在体外具有促有丝分裂活性。目的:与胰岛素样生长因子-1(IGF-1)相比,本研究着重研究胰岛素诱导血管平滑肌细胞(SMC)增殖和迁移的途径,因为它们是动脉粥样硬化的两个基本现象,还有助于了解胰岛素在衰老过程中的作用。方法:在胰岛素或IGF-1受体阻断抗体存在下,与胰岛素或IGF-1孵育后,测量培养的SMC中溴脱氧尿苷DNA的掺入,趋化性和膜褶皱的出现。结果:胰岛素通过IGF-1受体诱导SMC增殖。实际上,胰岛素受体的阻断并不能抑制胰岛素的促有丝分裂作用。相反,通过阻断胰岛素受体而不是IGF-1受体可以抑制胰岛素诱导的细胞迁移。但是,在来自非融合培养物的分化程度较低的SMC中,迁移反应明显更高,胰岛素丧失了其受体特异性。它通过胰岛素和IGF-1的受体被刺激。在这些情况下,IGF-1的作用相似。胰岛素诱导的F-肌动蛋白重排通过两种受体发生,但IGF-1通过其自身的受体更具特异性。结论:胰岛素激活的诱导SMC增殖的途径与IGF-1没有差异,而诱导生长细胞迁移的非特异性机制似乎与更高的敏感性反应有关。具有最高有丝分裂活性的细胞具有最高的迁移率,其中胰岛素或IGF-1失去对受体特异性的刺激。将这些结果推论到体内,胰岛素可能与诱导稳定以及衰老的副作用有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号